LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population-Reference-Cited by-同舟云学术

LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population

Published:2024-06 Issue:6 Volume:5 Page:570-582.e4
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Liu Shanghao,Chen Xiaohan,Jiang Xuanwei,Yin Xiaochun,Fekadu Ginenus,Liu Chuan,He Yan,Chen Huihui,Ni Wenjing,Wang Ruiying,Zeng Qing-Lei,Chen Yuping,Yang Ling,Shi Ruihua,Ju Sheng-Hong,Shen Jie,Gao Jingli,Zhao Linhua,Ming Wai-kit,Zhong Victor W.,Teng Gao-Jun,Qi Xiaolong^ORCID

Funder

Southeast University

Publisher

Elsevier BV

Reference46 articles.

1. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study;Serra-Burriel;Lancet,2023

2. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study;van Mil;Lancet,2023

3. Liver cirrhosis;Ginès;Lancet,2021

4. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases;Ginès;Hepatology,2022

5. Screening for liver fibrosis in the general population: a call for action;Ginès;Lancet. Gastroenterol. Hepatol.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of blood-based liver fibrosis scores in the Mount Sinai Health System, MASLD Registry, and NHANES 2017–2020 study;Hepatology Communications;2024-08-26

2. Population screening for cirrhosis;Hepatology Communications;2024-08-26

3. Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD;Clinical Gastroenterology and Hepatology;2024-07